5 Best Stocks to Buy Now According to Billionaire Jeffrey Talpins

In this article, we discuss the 5 Best Stocks to Buy Now According to Billionaire Jeffrey Talpins. For an in-depth study of Element Capital’s background, investment philosophy, and hedge fund performance, go directly to 10 Best Stocks to Buy Now According to Billionaire Jeffrey Talpins.

05. Pfizer Inc. (NYSE:PFE)

Element Capital’s Stake Value: $5.568 million

Percentage of  Element Capital’s 13F portfolio: 2.79%

Number of  Hedge Fund Holders: 70

At the end of the second quarter of 2022, 70 hedge funds in the database of Insider Monkey held stakes worth $2.8 billion in Pfizer Inc. (NYSE:PFE), compared to 79 in the preceding quarter worth $4.1 billion. During Q2 2022, Element Capital increased its stake in the company by 51% to $5.568 million, which represented 2.79% of its 13F portfolio. With a position worth $533.91 million, AQR Capital Management was the largest hedge fund holder in the company during Q2.

In its Q4 2021 investor letter, ClearBridge Investments, an asset management firm, highlighted a few stocks and Pfizer Inc. (NYSE:PFE) was one of them. Here is what the fund said:

“While the level of general turnover abated as we progressed through 2021, it remained high in one area: post-COVID-19 recovery plays. The concept behind this investment thesis was, and still is, straightforward: with the advent of effective vaccines, the path from pandemic to endemic is just a matter of time. As this transition occurs, the estimated excess savings of over $2 trillion built up on U.S. consumer balance sheets will unlock dramatic pent-up demand for experiences, especially global travel. This investment case seemed especially compelling when the Pfizer Inc. (NYSE:PFE) vaccine positively surprised markets in November 2020. As a result, we made post-COVID-19 stocks (which were trading well below our estimate of recovery value) a sizable theme within the portfolio. We understood this to be a more aggressive tilt in positioning because it required a major improvement in demand to catalyze fundamentals and drive price toward higher business values. (…read more)